Biomarkers to noninvasively determine the atrial fibrillation progression phenotype: A bridge to individualized ablative therapy?

Heart Rhythm. 2018 Aug;15(8):1138-1139. doi: 10.1016/j.hrthm.2018.03.040. Epub 2018 Apr 4.

Authors

Roeliene Starreveld¹, Natasja M S de Groot²

Affiliations

¹ Department of Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
² Department of Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: n.m.s.degroot@erasmusmc.nl.

PMID: 29625276
DOI: 10.1016/j.hrthm.2018.03.040

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Atrial Fibrillation*
Biomarkers
Humans
Natriuretic Peptide, Brain*
Peptide Fragments
Phenotype

Substances

Biomarkers
Peptide Fragments
pro-brain natriuretic peptide (1-76)
Natriuretic Peptide, Brain